Douglas W. Losordo's most recent trade in Cadrenal Therapeutics Inc was a trade of 150,000 Stock Options done . Disclosure was reported to the exchange on Jan. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics Inc | Douglas Losordo W. | Chief Medical Officer | 18 Jan 2024 | 150,000 | 150,000 | - | - | Stock Options | ||
| Longeveron Inc (Class A) | W. Losordo Douglas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Longeveron Inc (Class A) | Douglas W. Losordo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| Longeveron Inc (Class A) | Douglas W. Losordo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 5,000 | 5,000 | - | 0 | Common stock |